Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

Research output: Contribution to journalReview article

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)e145-e152
JournalStroke
Volume49
Issue number4
DOIs
Publication statusPublished - 2018 Apr 1

Keywords

  • cell- and tissue-based therapy
  • cerebral infarction
  • clinical trial
  • regenerative medicine
  • stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialised Nursing

Cite this

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction (2018). Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products. Stroke, 49(4), e145-e152. https://doi.org/10.1161/STROKEAHA.117.019216